Cholangiocarcinoma, also known as bile duct cancer, is a rare and aggressive form of cancer that originates in the bile ducts. These ducts play a crucial role in digestion by transporting bile from the liver to the gallbladder and small intestine. Bile is a fluid that helps the body digest fats.
Benjamin Olorunfemi
Cholangiocarcinoma, also known as bile duct cancer, is a rare and aggressive form of cancer that originates in the bile ducts. These ducts play a crucial role in digestion by transporting bile from the liver to the gallbladder and small intestine. Bile is a fluid that helps the body digest fats.
Cholangiocarcinoma cancer is classified based on its location:
- Intrahepatic cholangiocarcinoma! Begins in the bile ducts within the liver.
- Extrahepatic cholangiocarcinoma! Begins in the bile ducts outside the liver and is further divided into perihilar (at the point where the main bile ducts leave the liver) and distal (further down the bile duct).
A key challenge with this cancer is that it often doesn’t show symptoms in its early stages. By the time symptoms appear, the cancer has often spread, making it difficult to treat effectively.
Currently, there’s no strong evidence showing a major surge in cholangiocarcinoma specifically in Nigeria or among people of African descent. However, some risk factors linked to this cancer (like liver fluke infections, hepatitis B/C, and cirrhosis) are present in Nigeria, which could contribute to cases.
Symptoms of cholangiocarcinoma can be subtle and often don’t appear until the disease is advanced. They can include:
- Jaundice (yellowing of the skin and whites of the eyes)
- Itchy skin
- Dark urine and pale, greasy stools
- Unexplained weight loss and loss of appetite
- Abdominal pain, especially on the right side under the ribs
- Fever and fatigue
Treatment options depend on the stage and location. They can include:
- Surgery! The primary treatment, when possible, is to remove the tumour. This may involve removing a portion of the bile duct or even part of the liver.
- Liver Transplant! In some specific cases, a liver transplant may be a curative option, particularly for certain types of hilar cholangiocarcinoma.
- Chemotherapy! Uses drugs to kill cancer cells and can be used to slow the disease and relieve symptoms in advanced cases.
- Radiation Therapy! Uses high-powered energy beams to destroy cancer cells.
- Other therapies! These can include targeted drug therapy, immunotherapy, or procedures like biliary drainage to relieve symptoms caused by blockages.
Challenges in Nigeria
Survival rates for cholangiocarcinoma in Nigeria are low due to several challenges, including:
– Late diagnosis! Many cases are diagnosed at an advanced stage, making treatment more difficult.
– Limited access to healthcare! Many Nigerians lack access to quality healthcare services, including cancer diagnosis and treatment.
– Lack of awareness! There is a need for increased awareness about cholangiocarcinoma and its symptoms.
– Alcohol & Aflatoxin Exposure! Heavy alcohol use and contaminated foods (like poorly stored grains) increase liver disease risk.
– Financial Barriers! The cost of diagnostics and treatment is often a major hurdle for patients. Without adequate health insurance or government support, many people simply cannot afford the care they need.
– Weak Advocacy! While cancer advocacy groups are growing in Nigeria, the movement is still in its early stages. Stronger advocacy is needed to prioritise cancer control on the national health agenda.
Ways Out (Solutions):
- Better Awareness – Educate people on symptoms (jaundice, abdominal pain, weight loss).
- Early Screening – Regular check-ups for high-risk groups (hepatitis patients, those with liver disease).
- Improved Sanitation – Reduce liver fluke infections with clean water and food safety.
- Vaccination – The hepatitis B vaccine can lower liver cancer risks.
- Access to Treatment – More cancer centres and affordable care for early detection and surgery/chemotherapy.
- Support research: Encourage research into the causes and treatment of cholangiocarcinoma.
Cholangiocarcinoma is rare but deadly, especially when caught late. Early detection saves lives. So, if someone has prolonged jaundice, unexplained weight loss, or severe itching, they should see a doctor immediately.
The ROHSI team is saying you can help in this fight against the surge of cancer-related help by:
- Share this article and other resources about cholangiocarcinoma with your network.
– Offer emotional support and connect individuals with resources and services.
– Advocate for increased funding and resources for cholangiocarcinoma research and treatment.
Together, we can make a difference and improve the lives of those affected by cholangiocarcinoma in Nigeria. Get involved today.
Rays of Hope Support Initiative (ROHSI)